Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: The Singapore breast screening project

Cancer

Volumn 82, Issue 8, 1998, Pages 1521-1528

  Ng, Eng Hen ^a,b   Ng, Fook Cheong ^a   Tan, Puay Hoon ^a   Low, Sze Chuan ^a   Chiang, Gilbert ^a   Tan, Kim Ping ^a   Seow, Adelene ^a   Emmanuel, Shanta ^a   Tan, Chor Hiang ^a   Ho, Gay Hui ^a  

^a MINISTRY OF HEALTH   (Singapore)

^b MOUNT ELIZABETH MEDICAL CENTRE   (Singapore)

Author keywords

Asian women; Breast carcinoma; Population based mammographic screening

Indexed keywords

ADULT; ARTICLE; ASIAN; BREAST CARCINOMA; CANCER INCIDENCE; CANCER SCREENING; CANCER STAGING; CARCINOMA IN SITU; CHINESE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEALTH EDUCATION; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OBSERVATION; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGAPORE;

AGED; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, PAPILLARY; FEMALE; HUMANS; INCIDENCE; LYMPHATIC METASTASIS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; SINGAPORE;

EID: 0032522926     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980415)82:8<1521::AID-CNCR14>3.0.CO;2-6     Document Type: Article

References (22)

1. Sharpiro S, Strax P, Venet L. Periodic breast cancer screening in reducing mortality from breast cancer. JAMA 1971;215: 17777-85.
2. Tabar L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Grontoft O, et al. Reduction in mortality from breast cancer after mass screening with mammography: randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985;1:829-32.
3. Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ 1988;288:943-8.
4. UK Trial of Early Detection of Breast Cancer Group. First results on mortality reduction in the UK Trial of Early Detection of Breast Cancer Group. Lancet 1988;2: 411-6.
5. Frisell J, Eklund G, Hellstrom L, Lidbrink E, Rutqvist LE, Sornell A. Randomised study of mammographic screening: preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 1991;18:49-56.
6. Nystrom L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Ryden S, et al. Breast cancer screening with mammography: an overview of Swedish randomised trials. Lancet 1993;341:973-8.
7. Alagaratnam TT, Wong J. Limitations of mammography in Chinese females. Clin Radiol 1985;36:175-7.
8. Ohuchi N, Yoshida K, Michio K, Ouchi A, Shiiba K, Ohnuki K, et al. Comparison of false negative rates among breast cancer screening modalities with or without mammography: Miyagi trial. Jpn J Cancer Res 1995;86:501-6.
9. Chia KS, Lee HP, Seow A, Shanmugaratnam K. Trends in cancer incidence in Singapore, 1968-1992. Singapore Cancer Registry Reprod No. 4, 1996.
10. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H, editors Trends in cancer incidence and mortality. IARC Scientific Publication No. 121, Lyon: IARC, 1993:411-32.
11. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
12. Jin F, Devesa SS, Zheng W, Blot W, Fraumeni JF, Gao Y-T. Cancer incidence trends in urban Shanghai, 1972-1989. Int J Cancer 1993;53:764-70.
13. Seow A, Duffy SW, McGee MA, Lee J, Lee HP. Breast cancer in Singapore: trends in incidence, 1968-1992. Int J Epidemiol 1996;25:40-45.
14. Forrest Committee 1986 breast cancer screening. Report to the Health Ministers of England, Wales, Scotland & Northern Ireland. London: DHSS, HMSO, 1986.
15. Fletcher SW, Black W, Harris R, Rimer BK, Shaprio S. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst 1993;85:1644-56.
16. Rosenberg RD, Lando JF, Hunt WC, Darling RR, Williamson MR, Linver MN, et al. The New Mexico Mammography Project: screening mammography performance in Albuquerque, New Mexico, 1991-1993. Cancer 1996;78:1731-9.
17. Schwartz GF, Feig SA, Patchefsky AS. Significance and staging of non-palpable carcinomas of the breast. Surg Obstet Gynecol 1988;166:6-10.
18. Radford DM, Cromack DT, Troop BR, Keller SM, Lopez MJ. Pathology and treatment of impalpable breast lesions. Am J Surg 1992;164:427-32.
19. Quality assurance guidelines for surgeons in breast cancer screening. NHSBSP Publication 20, 1992.
20. Tabar L, Fagerberg G, Day NE, Holmberg L. What is the optimal interval between mammographic screening examinations? an analysis based on the latest results of the Swedish two county breast cancer screening trial. Br J Cancer 1987;55:547-51.
21. Burrell HC, Sibbering M, Wilson ARM, Pinder SE, Evans AJ, Yeoman LJ, et al. Screening interval breast cancers: mammographic features and prognostic factors. Radiology 1996;199:811-7.
22. Day NE, Williams DR, Khaw KT. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 1989;59:954-8.